Whether acting as a vehicle for waste clearance or templated protein aggregation, the presence of TDP-43 in biofluid-derived EVs alone has great relevance as a potential biomarker in TDP-43 proteinopathies [24, 25]. Here, TARDBP is linked to proteostasis deficiencies.